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Summary. Human osteoblasts (HOBs) support the growth
of human haematopoietic progenitor cells, and support
the survival and limited expansion of long-term culture-
initiating cells. Using human CD341 cells and the murine
myelomonocytic cell line NFS-60 as targets, we previously
found that one component of HOB-derived haematopoietic
activity is cell-associated granulocyte colony-stimulating
factor (G-CSF). However, antibody failed to neutralize all the
activity, suggesting that more than one factor supports
haematopoietic cells. In the present investigations, we asked
whether the HOB-derived, non-G-CSF secreted activity was
as a result of other known growth factors. We found that,
among the cytokines expressed by HOBs, only hepatocyte
growth factor (HGF) and G-CSF stimulated NFS-60 cell
proliferation. HOB cells and osteosarcoma cells secreted
biologically active HGF, although the levels varied considerably.
Moreover, addition of neutralizing HGF antibody to CD341
cell/HOB co-cultures resulted in a significant reduction
(<50%) in the ability of the HOBs to support haematopoietic
progenitor cells. These results suggest that a major
component of osteoblast-derived haematopoietic activity is
HGF. Secretion of HGF, in concert with cell-associated
cytokines such as G-CSF, may account for the stem cell-
stimulating activities of osteogenic cells and, thereby, the
unique stem cell-supporting role of the osteoblasts within
the bone marrow microenvironment.
Keywords: osteoblasts, progenitor cells, bone marrow,
hepatocyte growth factor, stem cells.
Haematopoiesis occurs in unique microenvironments in vivo
that facilitate the maintenance of haematopoietic stem cells
as pluripotent, while supporting lineage commitment of the
expanding blood cell populations. Each of these activities
may require different growth factors and microenviron-
ments, the identities of which have yet to be determined.
Within the bone marrow microenvironment, haematopoie-
tic growth factors are produced by resident stromal cells
(Dexter et al, 1977; Eaves et al, 1991; Guba et al, 1992;
Kittler et al, 1992). Marrow stromal cells are comprised of
several different populations including fibroblasts, macro-
phages, endothelial cells and adipocytes. Moreover, each of
these adherent cells probably represents local bone marrow
specializations of a widely expressed lineage.
One stromal cell type with a highly restricted expression is
the osteoblast. It has long been appreciated that endosteal
osteoblasts and haematopoietic stem cells are immediately
juxtaposed in vivo (Lord et al, 1975; Gong, 1978; Gartner &
Kaplan, 1980; Deldar et al, 1985; Hermans et al, 1989;
Lord, 1990), but the functional implications of this
apposition remains unknown. Recently, we have begun to
address the haematopoietic role of osteoblasts using normal
primary osteoblasts derived from human bone explants
(Taichman & Emerson, 1994; Taichman et al, 1996, 1997a,
b) and osteosarcoma cell lines (Taichman & Emerson, 1994;
Taichman et al, 1996). We have determined that primary
human osteogenic cells (HOBs) produce several haemato-
poietic growth factors that stimulate haematopoietic pro-
genitor cell maintenance and proliferation, and that human
osteogenic cells support the limited expansion of long-term
culture-initiating cells (LTC-ICs) derived from human
CD341 bone marrow cells in vitro (Taichman & Emerson,
1994; Taichman et al, 1996). To biochemically characterize
the haematopoietic activities of HOBs, we have utilized
transformed cell lines to model both early haematopoietic
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cells and osteogenic cells. Using the murine myelomyocytic
cell line NFS-60, we have determined that the part of the
activity produced by HOBs that is active on human CD341
bone marrow cells is granulocyte colony-stimulating factor
(G-CSF). G-CSF is currently the only human growth factor/
cytokine known to stimulate proliferation of NFS-60 cells
(Shirafuji et al, 1989). However, not all of the activity that
stimulates NFS-60 cell growth produced by primary osteo-
genic cells or human osteosarcomas is owing to G-CSF
(Taichman & Emerson, 1994).
In this report, we present data indicating that HOBs and
several osteosarcoma cell lines express and secrete hepato-
cyte growth factor (HGF). Moreover, the secreted HGF, in
collaboration with other haematopoietic activities secreted
by osteogenic cells including G-CSF, is required to support
the survival of early haematopoietic progenitor cells and the
proliferation of the NFS-60 cell line. HGF derived from
normal osteogenic cells also appears to contribute to the
support of normal progenitor cell proliferation. These results
suggest that a major portion of osteoblast-derived haema-
topoietic cell stimulatory activities may be owing to HGF.
Secretion of HGF may account for the stem cell stimulation
of osteogenic cells and thereby the unique stem cell
supporting role of the osteoblast within the bone marrow
microenvironment.
MATERIALS AND METHODS
Cell lines. Several human osteosarcoma cell lines were
purchased from the American Tissue Type Collection
(ATCC; Rockville, MD, USA) including G292 (CRL1423),
HOS TE85 (CRL1743), MG-63 (ATCC CRL1424), SaOS-2
(ATCC 85-HTB) and U-2 OS (ATCC HTB96). The cell lines
were maintained in Dulbecco's minimal essential medium
(DMEM) with Earle's salts or McCoys' 5A medium, 10%
heat-inactivated fetal bovine serum (FBS) and antibiotics.
Murine NFS-60 cells, a myeloid progenitor line that
proliferates in response to multiple murine cytokines but is
only known to proliferate in response to human G-CSF (a
kind gift from Dr James Ihle, St Jude Children's Research
Hospital, Memphis, TN, USA), were maintained in Roswell
Park Memorial Institute (RPMI)-1640 medium with 10%
FBS and 10% WEHI-3 (ATCC TIB68) conditioned medium.
Unless otherwise stated, all tissue culture reagents were
purchased from Life Technologies, Grand Island, NY, USA.
Primary human osteoblast-like cells (HOBs). Enriched
human osteoblast cultures were established using a
modifications of methods described by Robey and Termine
(1985). Normal human trabecular bone was obtained from
patients undergoing orthopedic surgery in accordance with
the University of Michigan's Investigational Review Board.
Bone cleaned of loosely adherent tissue was ground to
produce a uniform particle size (size # 1 mm2) (BioComp
Minimill, W. Lorenz, Jacksonville, FL, USA) and incubated in
1 mg/ml bacterial collagenase (Type P, Boehringer Man-
nheim Biologicals, Indianapolis, IN, USA). The explants
were placed into culture until confluent monolayers were
produced in a 1:1 (v/v) mixture of Ham's F12/DMEM
(Biofluids, Rockville, MD, USA) with low Ca21 and 10%
heat-inactivated FBS. Thereafter, the cultures were main-
tained in calcium-replete Ham's F12/DMEM (1:1 v/v)
medium containing 10% heat-inactivated antibiotics,
10 mmol/l b-glycerol phosphate and 10 mg/ml l-ascorbate.
To verify that the cells expressed an osteoblast phenotype,
the cultures were screened for the expression of the
osteoblast-specific protein osteocalcin (osteocalcin1) using
reverse transcriptase-polymerase chain reaction (RT-PCR),
as previously detailed (Taichman & Emerson, 1994, 1996).
In addition, the HOB cells express several additional features
of the osteoblast phenotype. These include expression of
mRNA, matrix Gla protein, osteonectin and type I collagen
(Gerstenfeld et al, 1987; Robey et al, 1987), high levels of
alkaline phosphatase activity are expressed by the HOB cells,
which, in primary culture, mineralize their extracellular
matrix, albeit weakly and only after extended culture
periods (Taichman & Hauschka, 1992). The cells do
not, however, express mRNA for bone sialoprotein (BSP),
nor do they appear to express parathyroid hormone (PTH)
receptors, as they fail to generate cAMP in response to
PTH or express mRNA for the receptor (unpublished
observations).
To evaluate the purity of the osteoblastic cells, we
utilitized stem cell factor as a marker of bone marrow
fibroblasts to determine the level of contamination we can
detect in fibroblast populations in our osteoblast prepara-
tions. We found that by mixing SCF(±) HOB populations with
SCF(1) stromal populations, we were able to detect a 1´0%
contamination of bone marrow stromal cells in a given
`osteoblast' preparation (Taichman et al, 2000a). Therefore,
as commonly used, the HOB populations are at least 99%
pure of contaminating stromal fibroblasts, with a possible
maximal contamination of 1% stromal cells. However, until
a `universal' human stromal cell marker is established that
clearly distinguishes immature osteoblasts from stromal
cells (i.e. not dependent upon late osteoblasts maturation
markers), it is not possible to rule out some level of stromal
fibroblastic cell contamination.
NFS-60 cytokine proliferation assays. NFS-60 cells were
washed three times in phosphate-buffered saline (PBS) and
1  104 cells were plated into triplicate 96-well flat-
bottomed tissue culture plates (Corning) in 0´1 ml of
Ham's F12/DMEM (1:1 v/v), containing 10% heat-inacti-
vated FBS, 100 U/ml penicillin G, 100 mg/ml streptomycin
sulphate, 10 mmol/l b-glycerol phosphate and 10 mg/ml l-
ascorbate. Log serial dilutions of recombinant human
cytokines were added alone or in combination with G-CSF
(0´001±10 ng/ml) over the following dose ranges; bone
morphogenic proteins (BMPs)-4, 5, 6, 7 (0´10±10 ng/ml,
Genetics Institute, Cambridge, MA, USA), endothelial
growth factor (EGF; 0´03±30 ng/ml), erythropoietin (0´02±
20 U/ml, Stem Cell Technologies, Vancouver, BC, Canada),
basic fibroblast growth factor (bFGF; 0´1±100 ng/ml),
FLT2/3-ligand (FL; 0´1±100 ng/ml, 200 ng/ml, Genzyme,
Cambridge, MA, USA), granulocyte macrophage colony-
stimulating factor (GM-CSF; 0´02±200 ng/ml), human
growth factor (HGF; 0´1±100 ng/ml, R & D Systems),
interleukin-1 alpha (IL-1a; 0´025±25 U/ml), IL-1b (0´03±
30 pg/ml), IL-3 (0´01±10 ng/ml), IL-4 (0´03±30 ng/ml),
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IL-5 (0´03±30 ng/ml), IL-6 (0´001±10 ng/ml), IL-7
(0´001±10 ng/ml), IL-10 (0´02±20 ng/ml, Peprotech,
Rockyhill, MN, USA), IL-11 (0´01±10 ng/ml), stem cell
factor (SCF; 0´05±50 ng/ml), leukaemia inhibitory factor
(LIF; 0´01±100 U/ml), lymphotoxin (LT; 0´01±10 ng/ml),
macrophage CSF (M-CSF; 0´001±100 U/ml), macrophage
inflammatory protein-1a (MIP-1a; 0´1±10 ng/ml), oncos-
tatin M (0´02±20 ng/ml), parathyroid hormone (PTH; 1 
1021121  1028 mol/l), PTH-related protein (PTHrP;
1  1021121  1028 mol/l), transforming growht factor-
b1 (TGF-b1; 0´1±100 ng/ml), thrombopoietin (TPO; 0´05±
5 ng/ml, 20 ng/ml), tumour necrosis factor-a (TNF-a;
1±100 U/ml, 500 U/ml). All cytokine reagents were
purchased from R & D Systems except where indicated.
Thereafter, the cultures were incubated in an atmosphere of
5% CO2 and 5% O2 at 378C for 4 d. Proliferation was
quantified using a colorimetric assay with 3-(4,5-dimethyl-
azol-2yl)-2,5-diphenyltetrazolium bromide (MTT; Sigma, St.
Louis, MS, USA) and read on a multiwell scanning
spectrophotometer (Molecular Devices, Sunnyvale, CA,
USA).
In some cases, proliferative responses to growth factors
were measured by [3H]-thymidine incorporation. For these
assays, at 90 h of culture, before the cultures reached
confluence, 18´5 kBq of [3H]-thymidine (SA  248´9 GBq/
mmol/l, New England Nuclear, Beverly, MA, USA) was
added to each well and the cells were harvested 6 h later
onto glass filters for scintillation counting. All data are
presented as either OD560 or CPM (mean^ standard deviation)
for triplicate determinations from three independent
experiments.
NFS-60 cell proliferation in dual-chambered co-culture with
MG-63 osteosarcomas. MG-63 human osteosarcoma or HOB
cells were seeded at an initial density of 2´0  104 cells/cm2
in Ham's F12/DMEM (1:1 v/v) (Life Technologies) contain-
ing 10% heat-inactivated FBS, antibiotics, 10 mmol/l b-
glycerol phosphate and 10 mg/ml l-ascorbate (Sigma, St.
Louis, MO, USA). After 5 days, the osteosarcoma cells were
washed twice in warm PBS and 1  104 NFS-60 cells were
seeded into the top chamber of the TransWell 24-well plates
(0´4 mmol/l pore size, Corning Costar, Boston, MA, USA)
with the confluent human osteosarcoma cells or HOBs in
the bottom chamber. Where indicated, neutralizing rabbit
polyclonal anti-human cytokine serum (or control) was
added daily to a final concentration of 0´05 mg/ml IL-1a,
IL-1b, G-CSF and TNF-a, 1 mg/ml HGF, 5 mg/ml aFGF and
LIF, and 30 mg/ml LT, IL-3, IL-4, KL and MIP-1a (R & D
Systems, Minneapolis, MN, USA or Genzyme, Cambridge,
MA, USA). Murine monoclonal antibodies to human GM-
CSF, IL-6, TGF-b or isotype-matched control (MOPC21,
Sigma) were added daily to 30 mg/ml final concentrations.
In some cases, 1  104 NFS-60 cells were seeded into the
top chamber of 24-well plates (non-contact) or in direct
contact with confluent HOBs or MG-63 osteosarcoma cells
in the bottom chamber, with 10 mg/ml of an affinity-
purified IgG fraction of neutralizing goat anti-human G-CSF
serum or 10 mg/ml of normal goat IgG serum or murine
monoclonal HGF (10 mg/ml) or control (MOPC21 IgG)
added daily. At 4 d, the NFS-60 cells were recovered and
absolute NFS-60 cell numbers were determined by manual
haemocytometer counting in PBS containing 0´4% trypan
blue (Sigma) and reported as mean ^ standard deviation
(n  3).
Reverse transcription polymerase chain reaction (RT-PCR).
HOBs and the osteosarcoma cells were plated at an initial
density of 2´0  105 cells/cm2 with complete medium
changes on d 5, d 7, d 10 and d 14 in medium containing
freshly prepared b-glycerol phosphate (10 mmol/l) and l-
ascorbate (50 mg/ml). Total cellular RNA was recovered on
d 14 by lysing the cells directly in Stat-60 according to the
directions of the manufacturer (Tel-Test, Friendswood, TX,
USA). RNA integrity and purity was checked using
electrophoresis with ethidium bromide and absorbency at
A260/A280. RNA (1´0 mg), 10 RT buffer (1 RT buffer:
50 mmol/l Tris HCl, pH 8´3, 50 mmol/l KCl, 8´0 mmol/l
MgCl2 and 10 mmol/l dithiothreitol), 25 mmol/l dXTP mix
(25 mmol/l of each dXTP; ACGT), 3´0 mg of oligo d(T) and
2´5 U of reverse transcriptase (M-MLV Reverse Transcrip-
tase, Life Technologies) were incubated together at 388C for
1 h. One-fifth of the double-stranded product was mixed
with 10 Taq buffer (1 Taq/RT buffer: 10 mmol/l Tris,
pH 8´3, 50 mmol/l KCl, 1´5 mmol/l MgCl2, 0´01% gelatin
and 2´0 mmol/l dithiothreitol), 1 mmol/l dXTP mix,
500 ng of each sense and antisense oligonucleotides, and
2´5 U of Taq polymerase (Taq polymerase, Life Technolo-
gies). Sense and antisense primers were prepared by the
oligonucleotide synthesis core at the University of Michigan
and were designed to cross intron/exon boundaries includ-
ing BMP-2 (5 0-ACC-CGG-GAG-AAG-GAG-GAG-G and 3 0-
CGG-TGA-TGG-AAA-CTA-CTA-TTG, expected size: 657 bp;
Oida et al, 1995), BMP-4 (5 0-GCC-ATT-CCG-TAG-TGC-CAT-
CC and 3 0-AAA-TAC-TCC-AAT-ACT-TCG-GG, expected size
688 bp; Oida et al, 1995), bFGF (5 0-GCC-TTC-CCG-CCC-
GGC-CAC-TTC-AAG-G and 3 0-GCA-CAC-ACT-CCT-TTG-ATA-
GAC-ACA-A, expected size 179 bp; Zaheer et al, 1995), FLT2/
3 ligand (5 0-AAT-CCG-TGA-GCT-GTC-TGA-CTA-C and 3 0-
GGA-GAA-GTT-CTG-GCG-AGT-GAT expected sizes 272 bp
and 312 bp; Zaheer et al, 1995), HGF primer set I (5 0-CTC-
CCC-ATC-GCC-ATC-CCC and 3 0-CAC-CAT-GGC-CTC-GCC-
TGG, expected size 749 bp; Borset et al, 1996), HGF primer
set II (5 0-TTC-AAC-TTT-GAA-CAC-TGA-CC and 3 0-ACAATG
CCTCTGGTTCCCCTT, expected size 384 bp; Sensebe et al,
1997), IL-1 (5 0-ATG-GCC-AAA-GTT-CGA-GAC-ATG and 3 0-
CTA-CGC-CTG-GTT-TTC-CAG-TAT-CTG-AAA-GTC-AGT,
expected size 815 bp; Brenner et al, 1989), IL-5 (5 0-ATG-
AGG-ATG-CTT-CTG-CAT-TTG and 3 0-TCA-ACT-TTC-TAT-TAT-
CCA-CTC-GGT-GTT-CAT-TAC, expected size 664 bp; Tanabe
et al, 1987), IL-7 (5 0-GGA-CTT-CCT-CCC-CTG-ATC-CTT-G
and 3 0-CTT-TGT-TGG-TTG-GGC-TTC-ACC-CAG, expected
size 377 bp; Thalmeier et al, 1996), IL-10 (5 0-ATG-CCC-
CAA-GCT-GAG-AAC-CCA-AGA and 3 0-GTC-GGG-TCA-GCT-
ATC-CCA-GAG-C, expected size 340 bp; Huettner et al,
1995), IL-11 (5 0-ATC-AAC-TGT-GTT-TGC-CGC-CTG-GTC
and 3 0-CGT-CAG-CTG-GGA-ATT-TGT-CCT-TC, expected size
201 bp; Thalmeier et al, 1996), LIF (5 0-CCT-GTG-CCA-TAC-
GCC-ACC-CAT-G and 3 0-GCC-TGG-GCC-AAC-ACG-GCG-ATG,
expected size 503 bp; Thalmeier et al, 1996), M-CSF (5 0-CCG-
AGG-AGG-TGT-CGG-AGT-ACT-G and 3 0-CTG-GCA-GTT-CCA-
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CCT-GTC-TGT-C, expected size 671 bp; Thalmeier et al, 1996),
MIP-1a (5 0-CTC-AGA-ATC-ATG-CAG-GTC-TCC-A and 3 0-
GGC-AAC-AAC-CAG-TCC-ATA-GAA-G, expected size 405 bp;
Davatelis et al, 1989), TPO (5 0-TCC-TCC-ACCA-GCA-GAC-
TGA-GCC-AGT and 3 0-GAG-TCC-ACG-AGT-TCC-ATT-CAA-
GAG, expected size 656 bp; Bartley et al, 1994) or as
previously detailed (Taichman & Emerson, 1994, 1996;
Taichman et al, 1997a).
The samples underwent thermal cycling at 948C for
1 min, 608C for 1 min and 728C for 1 min for 35 cycles,
followed by a 10-min extension at 728C (Perkin Elmer Cetus
DNA thermal cycler, Foster City, CA, USA). The products
were electrophoresed in 3% agarose and visualized using
ethidium bromide. To control for false positives or DNA
contamination, reverse transcriptase was omitted from the
reaction (data not presented). Positive controls included
RNA from IL-1b- and TNF-a-stimulated stromal cells or
peripheral blood lymphocytes stimulated with phytohae-
magglutinin (PHA) and phorbol 12-myristate 13-acetate
(PMA). Whole blood cells were separated by density
centrifugation over Ficoll-Hypaque and separated by adher-
ence to plastic. The non-adherent blood cells were cultured
overnight in Iscove's modified Dulbecco's medium (IMDM)
with 10% FBS, 10% horse serum, 1 mmol/l hydrocortisone
with the non-adherent layers removed after 48 h and
stimulated for a further 48 h with IL-1b (250 pmol/l) and
TNF-a (1´0 nmol/l) (R & D Systems). Human bone marrow
stromal cells were obtained from healthy adult volunteers by
iliac crest puncture and aspiration into preservative-free
heparin under a protocol approved by the University of
Michigan's Investigational Review Board. Mononuclear cells
were isolated by density separation on Ficoll-Hypaque
(specific gravity 1´077). Plastic adherence at 378C was
performed in modified Dexter's medium (IMDM, 10% FBS,
10% equine serum, 1 mmol/l hydrocortisone, penicillin/
streptomycin; Life Technologies). Following overnight adher-
ence, the non-adherent cells were removed and the cultures
were passaged at confluence three times. For positive
controls, at the final passage, the bone marrow stromal
cells were replated at an initial density of 1  104 cells/cm2
and stimulated at confluence with IL-1b (250 pmol/l) and
TNF-a (1´0 nmol/l) for 48 h.
Cytokine ELISAs. ELISAs were performed using the
double-antibody sandwich method with commercially
available kits (R & D Systems). Based upon parallel assays
of known standards, the sensitivities of the assays of
unconcentrated conditioned medium were: G-CSF 39±
2500 pg/ml; GM-CSF 8±500 pg/ml. Aliquots of conditioned
medium were concentrated twofold by centrifugation at
1000 g in a 258C fixed angle JA-17 rotor (Beckman, Palo
Alto, CA, USA) in Centricon-10 concentrators (Amicon
Division of W. R. Grace, Danvers, MA, USA) until the desired
volume was reached. Used in conjunction with concen-
trated medium, the G-CSF and GM-CSF ELISAs were able to
detect concentrations as low as 19 pg/ml and 4 pg/ml
respectively. Matched antibody capture and detection
antibodies were utilized to construct an ELISA for HGF
from commercially available components (R & D Systems).
Isolation of human CD341 bone marrow cells. Human bone
marrow cells were obtained from healthy adult volunteers
by iliac crest puncture and aspiration into preservative-free
heparin under a protocol approved by the University of
Michigan's Investigational Review Board. Mononuclear cells
were isolated by density separation on Ficoll-Hypaque
(specific gravity 1´077). Plastic adherence at 378C was
performed in modified Dexter's medium (IMDM, 10% FBS,
10% equine serum, 1 mmol/l hydrocortisone, penicillin/
streptomycin; Life Technologies). Following overnight adher-
ence, the non-adherent cells were recovered and CD341
bone marrow cells isolated by positive immunomagnetic
selection using the QUIND/10 antibody (Miltenyi Biotec,
Sunnyvale, CA, USA). In some experiments, the non-
adherent bone marrow mononuclear CD341 cells that
were isolated by positive immunomagnetic selection (Milte-
nyi) were stained with a phycoerythrin conjugate of the
anti-CD34 antibody, HPCA-2 (Becton Dickinson, San Jose,
CA, USA), and sorted by fluorescence-activated cell sorting
(EPICS C, Coulter, Hialeah, FL, USA) to evaluate purity.
Under these conditions, 92´5 ^ 5% (n  2) of the recovered
cells expressed the CD34 antigen.
Liquid co-culture of CD341 bone marrow cells and primary
human osteogenic cells. Primary human osteogenic cells
(HOBs) at confluence were harvested by trypsinization
(20 min, 378C, 0´05% trypsin/0´5 mmol/l EDTA, Gibco-
BRL) and seeded into a 96-well plate at a final density of
2  104/cm2 in Ca12-replete Ham's F12/DMEM (1:1 v/v)
with 10% heat-inactivated FBS, antibiotics, 10 mmol/l b-
glycerol phosphate and 10 mg/ml l-ascorbate. After 7 d, the
osteoblast monolayers were washed twice and CD341 bone
marrow cells were seeded onto the osteoblast monolayers.
After 2 weeks, all of the cultures were harvested by
trypsinization (20 min, 378C, 0´05% trypsin/0´5 mmol/l
EDTA) and either prepared for light microscopy (cell number
and morphology was determined) or the cells were replated
in colony-forming progenitor cell assays in methylcellulose
containing IL-3, GM-CSF and erythropoietin. The effect of
osteoblast-derived HGF or G-CSF on the progenitor cell
survival was compared by daily addition (to a final
concentration of 1 mg/ml) of neutralizing anti-HGF mono-
clonal antibodies (R & D Systems), IgG1 control (MOPC 21,
Sigma) or vehicle during the 2 week co-culture period. After
2 weeks, haematopoietic colonies were scored as granulo-
cyte macrophage colony-forming units (CFU-GM), erythroid
burst-forming units (BFU-E) or mixed lineage CFUs (CFU-
GEMM) using light microscopy. In some cases, the effect of
increasing does of G-CSF or HGF were directly incorporated
into the progenitor assays.
Statistical analyses. Analysis of variance (anova) was
utilized to determine statistical significance to a level of
P , 0´05.
RESULTS
We recently reported that normal human osteogenic cells,
as well as human osteosarcoma cell lines, constitutively
produce G-CSF capable of stimulating the proliferation of
normal human CD341. Based on experiments using
neutralizing antibodies to human G-CSF and porous
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micromembrane assays, we determined that not all the
osteoblast-derived stimulatory activity was attributable to G-
CSF (Hara et al, 1988; Metcalf, 1989; Shirafuji et al,
1989;Taichman & Emerson, 1994). Therefore, to determine
if other known cytokines were responsible for the additional
non-G-CSF haematopoietic activities produced by osteogenic
cells, we addressed the following questions: (i) what known
cytokines do osteogenic cells produce?, (ii) do haematopoie-
tic cells proliferate in response to other known cytokines
alone or in combination with G-CSF?, and (iii) can we
inhibit haematopoietic cell proliferative activity produced by
osteoblast cell lines with specific anti-cytokine neutralizing
antibodies? To address these questions we used the
murine myelocytic leukaemia cell line NFS-60 to model
osteoblast±haematopoietic cell interactions and subsequently
confirmed these findings with CD341 cells.
Expression of cytokines by human osteosarcomas and osteoblasts
MG-63 human osteosarcoma cell lines were cultured in the
presence of l-ascorbate and b-glycerol phosphate to induce
osteoblast phenotype as previously detailed (Taichman &
Emerson, 1996). After 14 d, RNA was isolated and
examined for mRNA expression of several cytokines. Using
the RT-PCR, we determined that MG-63 cells constitutively
expressed mRNA for BMP-4, bFGF, FLT-ligand (FL), IL-7, M-
CSF and LIF. No mRNA was consistently detected for BMP-2,
IL-5, IL-10, oncostatin M and thrombopoietin (TPO) in MG-
63 cells under the culture conditions tested (Fig 1). These
data supplement our previous report that MG-63 cells
express mRNA for G-CSF, IL-1b, IL-6, GM-CSF, TGF-b1 and
TNF-a, but failed to express mRNA for KL, IL-3 or LT
(Taichman & Emerson, 1996).
Using RT-PCR we also determined that mRNA for HGF
was expressed by both MG-63 cells and primary human
explant-derived osteogenic cells (HOBs) (Fig 2A). This was
of considerable interest as HGF has recently been demon-
strated to stimulate NFS-60 proliferation when in direct
contact with a preadipocyte cell line (Satoh et al, 1997). To
further verify that the expression of HGF mRNA is a general
feature of osteosarcomas, we evaluated whether G292, HOS
TE85, SaOS-2 and U2±0S cells also expressed HGF. Here, we
noted that HOS TE85 and U2±0S cells expressed HGF
mRNA, whereas G292 and U2±0S did not (Fig 2B), yet
NFS-60 do proliferate on these cells, suggesting an as yet
unidentified activity (data not presented). Using a sandwich
ELISA, we found that MG-63 cells secrete easily detectable
quantities of HGF (15 542 ^ 878 pg/ml/104cell/4 d,
n  3). Primary HOBs also secreted detectable HGF,
although the levels produced by primary HOB cells
varied from marrow donor to donor (3547 ^ 604
vs133 ^ 45 pg/ml/104cell/4 d) (Fig 2C).
NFS-60 cell proliferation in G-CSF alone and in combination
with test cytokines
We next measured the ability of NFS-60 cells to proliferate
in response to recombinant cytokines whose mRNA had
been detected by RT-PCR in osteosarcoma cells. Over 4 d,
NFS-60 cells proliferated in response to G-CSF, but failed to
proliferate in response to BMP-4, aFGF, IL-1a, IL-1b, IL-4,
IL-5, IL-6, IL10, IL-ll, FL, GM-CSF, oncostatin M, PTHrP, LIF,
LT, TNF-a or TPO. Similarly, NFS-60 cells did not proliferate
Fig 1. Reverse transcriptase PCR (RT-PCR)
detection of cytokine mRNAs by MG-63
cells. RT-PCR was performed using primers
designed to cross intron±exon boundires.
Negative controls omitted reverse tran-
scriptase from the reverse transcription
reaction. Where indicated, positive controls
included RNA from IL-1b- and TNF-a-
stimulated stromal cells or peripheral blood
lymphocytes stimulated with PHA and
PMA.
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in response to BMP-5, BMP-6, BMP-7, EGF, EPO, IL-2, IL-3,
IL-12, SCF or MIP-1a. Furthermore, none of these cytokines
increased the ability of NFS-60 cells to proliferate in
response to G-CSF (Fig 3A).
In contrast, the concentrations of HGF secreted by both
MG-63 cells and primary HOBs were sufficient to stimulate
the proliferation of NFS-60 cells. HGF alone, at concentra-
tions of 1´0 ng/ml or higher, stimulated NFS-60 cell
proliferation, although the magnitude of the response was
not robust. However, when combined with low (0´01 ng/
ml) concentrations of G-CSF, HGF synergized to stimulate
the NFS-60 cell proliferation (Fig 3B).
NFS-60 cell proliferation in dual-chambered co-culture with
human osteosarcomas
Previously, we observed that osteogenic cells stimulate the
proliferation of NFS-60 cells in co-culture. However,
osteoblast-conditioned medium failed to induce NFS-60
proliferation (Taichman & Emerson, 1994). Verfaillie (1992)
demonstrated that stromal cell-dependent haematopoiesis
depends in part on short-lived soluble factors that may
require high local concentrations for activity. Based upon
these observations, NFS-60 cells were placed in TransWell
co-culture with MG-63 monolayers for 4 d. Thereafter, the
NFS-60 cells were recovered by washing the membranes
with trypsin to ensure that all the plated cells were
recovered. On average, the cell number increased fivefold
during the culture period, demonstrating that some of
the osteoblast-derived activity did not require cell-to-cell
contact.
Using this dual-chambered co-culture system, neutraliz-
ing antibodies to each of the cytokines whose messages were
detected by RT-PCR were added to individual cultures. Of
these, the only anti-human cytokine antibody that reduced
NFS-60 proliferation was G-CSF and only when the cells
were in direct contact with one another (Taichman &
Emerson, 1994; Taichman et al, 1996). When the cells were
separated from one another by porous micromembranes,
however, antibody to G-CSF did not alter proliferation of the
NFS-60 cells (Fig 4A). These data are consistent with our
previous findings that primary osteoblasts and osteosar-
coma cell lines express G-CSF preferentially in a cell-
associated, rather than soluble, form in the absence of
inflammatory mediators (Taichman & Emerson, 1994;
Taichman et al, 1996). Incubation with anti-TGF-b anti-
body increased NFS-60 cell proliferation (Fig 4A).
Next, we confirmed that the immunoreactive HGF protein
secreted by osteoblasts and osteosarcoma cells was biologi-
cally active. When NFS-60 cells were cultured while
separated from the adherent cells by porous membranes
(Fig 3B) or in direct contact with the adherent cells
(Fig 4B), NFS-60 proliferation was observed. Neutralizing
antibody to human HGF caused a significant decrease in
proliferation of the NFS-60 cells under both contact and
non-contact conditions on MG-63 cells. Furthermore, under
culture conditions in which HOB and NFS-60 cells were in
direct contact, the inhibitory effect of anti-HGF antibody
was enhanced by the addition of an anti-G-CSF antibody
(Fig 4B).
Does HGF produced by osteogenic cells support haematopoietic
progenitor cells?
To directly determine if HGF produced by HOBs contributes
Fig 2. Synthesis of HGF by HOB cells and human osteosarcomas.
A. RT-PCR was performed (35 cycles) to detect mRNA for GADPH
and two sets of HGF primers from mRNA recovered from primary
human osteogenic cells and MG-63. B. RT-PCR was performed on
mRNA recovered from G292, HOB, HOS TE85, MG-63, SaOS-2 and
U2-OS for HGF and actin. Primers were designed to cross intron/
exon boundaries. Negative controls included omitting reverse
transcriptase (not shown) from the reverse transcription reaction
or H20 (neg control). C. HOBs and MG-63 cells were seeded
(1´0  104) in 24-well tissue culture plates with 10% FBS. 96 h
after confluence, the cells were washed and re-fed. Conditioned
medium was collected and assayed for HGF by ELISA. Representa-
tive data from three independent experiments are presented as a
mean ^ standard pg/ml HGF deviation for triplicate determinations.
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to the survival of haematopoietic progenitor cells in vitro,
CD341 cells were cultured for 2 weeks in the presence of
human osteogenic cells and/or neutralizing anti-HGF anti-
body. At the conclusion of the assay, the cells were
recovered, cell numbers normalized and assays performed
for progenitor cell activity. In the absence of HOB mono-
layers, no colony formation was observed (Fig 5). In the
presence of HOB monolayers, maintenance of progenitor cell
activity was observed (92´3 ^ 7% input). The addition of
the anti-HGF antibody resulted in a significant reversal in
the ability of osteogenic cells to support haematopoietic
progenitor cells, reducing the ability of the HOBs to support
progenitor cell proliferation by approximately 50% (Fig 5).
Finally, to directly assay the role of HGF in the ability of
HOBs to support normal human haematopoietic progenitor
cells in vitro, we determined whether the combination of G-
CSF and HGF alone was sufficient to support the formation
of haematopoietic colonies in vitro. For these investigations,
CD341 bone marrow cells were cultured for 2 weeks in
methylcellulose and the presence or absence of increasing
doses of recombinant G-CSF and HGF. At the conclusion of
the culture period, progenitor cell activity was as shown in
Fig 6. Increasing concentrations of both G-CSF and HGF
produced significantly greater colonies together, than either
cytokine alone.
DISCUSSION
These data demonstrate that osteoblast-derived HGF plays
an important role in the ability of osteogenic cells to support
haematopoiesis. Using RT-PCR and ELISA methods, we
determined that primary human osteogenic cells and MG-
63 cell lines constitutively secrete HGF. NFS-60 cells were
also shown to proliferate in response to HGF and the
proliferative activity was synergistic with suboptimal doses
of G-CSF. When HGF activity was neutralized using
monoclonal antibodies, a significant reduction in the ability
of osteogenic cells to support NFS-60 cell proliferation was
observed. Most importantly, neutralization of HGF resulted
in a reduction in the ability of osteogenic cells to support the
survival of primary haematopoietic progenitor cells. Further-
more, the proliferative activity produced by osteogenic cells
Fig 3. NFS-60 proliferation in recombinant
human cytokines. A. Log serial dilutions of
recombinant human cytokines were added
to 1  104 NFS-60 cells as reported in the
Patients and Methods. Proliferation was
quantified at the conclusion of 4 d of
culture by colorimetric assay using 3-(4,5
dimethylazol-2yl)-2,5-diphenyltetrazolium
bromide (MTT) at A560 (OD560 vertical
scale) on an ELISA plate reader (Molecular
Devices) or by [3H]-thymidine incorporation
over a 6-h period (CPM vertical scale). B.
Log dilutions of recombinant human HGF
alone (insert) or in combination with G-CSF
were added to 1  104 NFS-60 cells. Data
are presented as mean ^ standard deviation
for triplicate determinations from a mini-
mum of three independent experiments.
*Significant difference from 0 HGF (insert)
or HGF alone, P , 0´05.
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was not as a result of the BMPs (2, 4, 5, 6, 7), Epo, bFGF, FL,
GM-CSF, IL-1a IL-1b, IL-3, IL-4, IL-5, IL-6, IL-7, IL-11, SCF,
LIF, LT, M-CSF, MIP-1a, oncostatin M, PTH, TNF-a or TGF-
b.
These findings contribute to our fundamental under-
standing of the role of osteogenic cells within the
haematopoietic microenvironment and the mechanisms by
which osteogenic cells and haematopoietic stem cells
interact. Previous studies have demonstrated that osteo-
genic cells support primitive haematopoietic stem cell
survival and proliferation, and support stem cell engraft-
ment in bone marrow transplantation (El-Badri et al, 1998;
Nelissen et al, 2000). However, the biochemical basis of the
haematopoietic activity of osteogenic cells has been
relatively obscure. Previous biochemical studies have failed
to detect secreted G-CSF from osteogenic cells, while only
cell-associated G-CSF has been demonstrated by Western
blot analysis and immunoprecipitation (Taichman et al,
1996). Of note, other haematopoietic co-mitogens such as
SCF have not been found to be produced by, or responsible
for, the haematopoietic supportive activity of the osteogenic
cells in our systems, further underscoring the concept that
haematopoiesis occurs on a network of cells of which
differentiated osteoblasts are a component. Within this
scope, our data suggest that HGF, in collaboration with
other haematopoietic growth factors such as G-CSF, may be
a central molecular player in stem cell survival and
proliferation supported by osteoblastic cells within the
bone marrow microenvironment. However, other haemato-
poietic activities produced by human osteoblasts remain to
be identified.
Recently, Satoh et al (1997) observed that the preadipose
cell line MC3T3-G2/PA6 (PA6) stimulated the proliferation
of NFS-60 cells when cultured in direct contact with each
Fig 4. Antibody inhibition of NFS-60 cell
proliferation in dual chambered co-culture
with MG-63 osteosarcoma cells. A. NFS-60
cells (2  104) were seeded into the top
chamber of TransWell 24-well plates
(0´4 mmol/l pore size) with confluent MG-
63 osteosarcoma cells in the bottom
chamber. Where indicated, neutralizing
rabbit polyclonal anti-human cytokine
serum (or control serum) was added daily to
a final concentration of 0´5 mg/ml (IL-1a,
IL-1b, G-CSF, TNF-a), 5 mg/ml (aFGF, LIF)
or 30 mg/ml (LT, IL-3, IL4, KL, MIP-1a).
Murine monoclonal antibodies to GM-CSF,
IL-6, TGF-beta or isotype-matched control
were added daily to 30 mg/ml final con-
centrations. Input was defined as the
number of NFS-60 cells placed in culture at
culture initiation. B. NFS-60 cells (2  104)
were seeded into the top chamber of
TransWell 24-well plates (0´4 mmol/l pore
size) with confluent HOBs or MG-63 osteo-
sarcoma cells in the bottom chamber (non-
contact), or in direct contact with MG-63
cells at a final density of 1  104 cells/well
in 96-well tissue culture plates for 4 d
(direct contact). Where indicated, (i) vehicle
(No Tx), (ii) 10 mg/ml of an affinity purified
IgG fraction of neutralizing goat anti-
human G-CSF serum, or (iii) 10 mg/ml of
normal goat IgG serum or murine mono-
clonal HGF (10 mg/ml) or control
(MOPC21) were added daily (R & D
Systems). Absolute NFS-60 cell numbers
were determined by manual haemocyt-
ometer counting and reported as mean
^ standard deviation (n  4) at 4 d. *Sig-
nificant difference from antibody or vehicle
control, P , 0´05 or **P , 0´01.
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other, in part owing to the production of HGF. In contrast to
these observations, we found that the proliferation of NFS-
60 cells in our osteosarcoma system was cell-contact
independent and could be attributed to secreted HGF.
However, it should also be noted that additional non-HGF
activity may be produced by osteosarcoma cells that may
support haematopoiesis, as G-292 and U2-OS cells support
NFS-60 proliferation without apparently producing HGF
(Fig 2B) in our system. Takai et al (1997) recently found
that HGF was produced within the bone marrow stromal
microenvironment. The present studies confirmed these
results and show that the secretion of HGF by stromal
osteogenic cells makes a substantial contribution to
haematopoietic cell proliferation (Takai et al, 1997). These
results may explain, at least in part, the recent findings that
osteogenic cells directly support the proliferation of stem
cells and their engraftment following allogeneic bone
marrow transplantation (El-Badri et al, 1998).
These observations suggest that HGF may be a critical
cytokine linking the physiology of osteogenic cells and the
haematopoietic marrow. Recombinant HGF is known to
stimulate the formation of colonies from haematopoietic
CD341 progenitor cells from human bone marrow, peri-
pheral blood or umbilical cord blood (Nishino et al, 1995;
Zarnegar & Michalopoulos, 1995; Goff et al, 1996). This
effect synergizes with the activity of G-CSF, GM-CSF, IL-3
and SCF (Galimi et al, 1994; Nishino et al, 1995; Goff et al,
1996, 1997) by either direct or indirect mechanisms
(Ratajczak et al, 1997). Conversely, HGF has been directly
linked to the metabolism of bone. HGF induces the
formation of osteoclasts in the presence of osteogenic cells
and it may even activate bone resorption (Fuller et al, 1995;
Ohnishi et al, 1997). HGF has been reported to both
enhance or decrease osteoblast proliferation (Inaba et al,
1993; Grano et al, 1996) and to increase expression of
alkaline phosphatase (Inaba et al, 1993). Two classes of HGF
receptors have been identified. Expression of the high
affinity HGF receptor c-Met is observed predominantly in
epithelial cells, but may be expressed by a variety of cells,
including bone marrow stromal cells, osteogenic cells and
osteosarcomas (Kmiecik et al, 1992; Gohda et al, 1994;
Takai et al, 1997).
HGF production by fibroblasts is enhanced by the addition
of heparin or phorbol ester, whereas dexamethasone and
TGF-b inhibit HGF production. Fibroblast HGF production is
upregulated by IL-1b and TNFa by increasing their basal
production of HGF (Matsumoto et al, 1992; Inaba et al,
1993; Gohda et al, 1994; Takai et al, 1997). Other agents,
including EGF, platelet-derived growth factor (PDGF), aFGF,
bFGF (Gohda et al, 1994) and cAMP-elevating agents such
as forskolin, cholera toxin and PGE2 (Tamura et al, 1993;
Matsunaga et al, 1994; Sugiyama et al, 1996) markedly
simulate the production of HGF. In contrast, little is known
concerning what regulates the production of HGF produced
by osteogenic cells. In preliminary investigations, it does
not appear that IL-1b and TNFa alter HGF production by
Fig 5. Survival of haematopoietic progenitor cells on HOBs.
Human CD341 bone marrow cells were seeded onto confluent
human osteoblast monolayers for 2 weeks in the presence or
absence of neutralizing monoclonal antibody to HGF. After 2 weeks,
the cells were recovered, counted and replated in methylcellulose in
the presence of cytokines (IL-3, GM-CSF and erythropoietin). After
two more weeks, total haematopoietic colonies were scored using
light microscopy. *Indicates significant difference from GF control
(P , 0´05).
Fig 6. G-CSF and HGF stimulate hemato-
poietic progenitor cells colony formation. To
directly assay the role of HGF in the ability
of HOBs to support normal human haema-
topoietic progenitor cells in vitro, CD341
bone marrow cells were cultured for
2 weeks in methylcellulose in the presence
or absence of increasing does of recombi-
nant G-CSF and HGF. At the conclusion of
the culture period, progenitor cell activity
was determined. After two more weeks,
total haematopoietic colonies were scored
using light microscopy. *Indicates signifi-
cant difference from GF control (P , 0´05).
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MG-63 cells (unpublished observations). We do not yet
know whether the haematopoietic cells themselves coop-
erate with osteogenic cells in the production of the HGF, as is
the case for osteoblast-derived IL-6 and possibly MIP-1a
(Taichman et al, 1997b, 2000b).
In summary, the present data demonstrate that HGF
contributes to the support of haematopoiesis by osteogenic
cells. The data support a model in which osteogenic cells, by
virtue of their direct proximity to primitive repopulating
stem cells and their production of HGF and G-CSF, play a
unique role in supporting stem cell survival and prolifera-
tion within the bone marrow microenvironment. Further
investigation will be required in order to determine the
biological basis of osteoblast-supported haematopoiesis, its
regulation and its precise role in stem cell survival,
maintenance and proliferation.
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